Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05757973 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT05757973
- Sponsor
- Janssen Research & Development, LLC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.